A new market research report by Transparency Market Research, titled “Stem Cell Umbilical Cord Blood Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024,” encapsulates an in-depth evaluation. This study is an effort toward presenting a clear picture on the condition of the stem cell umbilical cord blood market in the coming eight years. The report encapsulates a micro level evaluation of the factors impacting the growth of the market. These include the major industry drivers, the prime market trends, opportunities, and challenges. The report includes the competitive scenario, market dynamics, and developments taking place in the market to enable the emerging players in designing their development strategies for gaining a competitive edge in the market. The market attractiveness evaluation, SWOT analysis, competitive analysis, and Porter’s five forces evaluation is also a key part of this study.
Get Free Sample Research Report:
Umbilical cord blood (UCB) is the blood that remains within the attached placenta and umbilical cord after childbirth. The stem cells within UCB are considered to be unique owing to their ability to treat numerous life-threatening diseases. These cells are also utilized for the treatment of hematopoietic and genetic disorders. UCB stem cells are gaining popularity in medical science due to their ability to be transformed into any kind of human cells.
As per the report, UCB stem cells have proven to be very effective for the treatment of over 80 diseases. Hence, the rising prevalence of chronic diseases such as diabetes, cancer, immune diseases, metabolic diseases, and blood diseases, among others have raised the demand for umbilical cord blood stem cells. In addition, these cells possess the unique property of having a great cell count in a lower volume of blood and their collection is much simpler as compared to other stem cells. These factors will further augment the growth of the market.
Furthermore, governments of a number of nations have been supporting research and clinical trials in cord blood stem cells, which in turn has increased the demand for these cells within the healthcare industry. This is resulting in the increased commercialization of UCB stem cell therapies by the major players, thus boosting the overall development of the market. However, the presence of strict rules in a number of nations may pose a challenge to the growth of the market. This is owing to the fact that cord blood isn’t collected and stored within all the operating hospitals globally.
Geographically, the report segments the market into Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. According to the report, the prime players operating in the stem cell umbilical cord market are Nuo Therapeutics, Cytori Therapeutics, and Teva Pharmaceuticals, among others.
Full Research Report on Global Stem Cell Umbilical Cord Blood Market: